GrippeEspagneV1, Main, Exploration, bibRecord, 000046

[Description of Influenza B in seasonal epidemics in Spain].

Identifieur interne : 000046 ( Main/Exploration ); précédent : 000045; suivant : 000047

[Description of Influenza B in seasonal epidemics in Spain].

Auteurs : R. Ortiz De Lejarazu [Espagne] ; J. Díez Domingo ; A. Gil De Miguel ; F. Martin N Torres ; C. Guzmán Quilo ; J M Guillén ; B. Piedrafita ; E. Redondo Marguello

Source :

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [ 1988-9518 ] ; 2018.

RBID : pubmed:30421881

Descripteurs français

KwdFr :
- Espagne (épidémiologie), Grippe humaine (prévention et contrôle), Grippe humaine (virologie), Grippe humaine (épidémiologie), Géographie (MeSH), Humains (MeSH), Saisons (MeSH), Sous-type H1N1 du virus de la grippe A (MeSH), Vaccins antigrippaux (immunologie), Virus de la grippe A (MeSH), Virus influenza B (MeSH), Épidémies (MeSH).
MESH :
- immunologie : Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- virologie : Grippe humaine.
- épidémiologie : Espagne, Grippe humaine.
- Géographie, Humains, Saisons, Sous-type H1N1 du virus de la grippe A, Virus de la grippe A, Virus influenza B, Épidémies.
Wicri :
- geographic : Espagne.

English descriptors

KwdEn :
- Epidemics (MeSH), Geography (MeSH), Humans (MeSH), Influenza A Virus, H1N1 Subtype (MeSH), Influenza A virus (MeSH), Influenza B virus (MeSH), Influenza Vaccines (immunology), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Seasons (MeSH), Spain (epidemiology).
MESH :
- chemical , immunology : Influenza Vaccines.
- geographic , epidemiology : Spain.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- virology : Influenza, Human.
- Epidemics, Geography, Humans, Influenza A Virus, H1N1 Subtype, Influenza A virus, Influenza B virus, Seasons.

Abstract

OBJECTIVE

Seasonal influenza epidemics are a major public health concern. They are caused by the influenza A and B viruses; although the A virus is more prominent, influenza B virus infection causes a disease with similar characteristics. There are two phylogenetically distinct influenza B lineages (B/Victoria and B/Yamagata), only one of which is present in the trivalent vaccine formulated each season.

METHODS

Epidemiological data from the Spanish Influenza Surveillance System for 2007 to 2017 were reviewed to establish the relative proportion of each type of virus and the characterization of the B lineages in relation to the composition of the trivalent vaccine.

RESULTS

The median proportion of B (2007-2017) was 27.2% (0.7%-74.8%) vs. 16.3% (0.4%-98.6%) for A-H3 and 44.2% (0.1%-98.0%) for pandemic A-H1N1 (20092017). The B lineages co-circulated in 8/10 seasons and there was mismatch with the B vaccine strain in 4/10 seasons. The B virus was dominant in 2007/08 and 2012/13 throughout Spain. There was a combination of dominance/codominance of influenza B and mismatch with the vaccine lineage in at least one third of epidemic seasons reviewed.

CONCLUSIONS

Epidemiological information on influenza B has been less compiled in comparison with data on the A virus. Influenza virus type B is responsible for a significant number of cases in almost all seasons. The predominant B lineage in each season is unpredictable, affecting the protection conferred by the seasonal vaccine. Spanish epidemiological data support the rationale for a quadrivalent vaccine with both B virus lineages similarly to data from other settings.

PubMed: 30421881
PubMed Central: PMC6254476

Affiliations:

Espagne

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 00035
to stream Main, to step Curation: 000035

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Description of Influenza B in seasonal epidemics in Spain].</title>
<author><name sortKey="Ortiz De Lejarazu, R" sort="Ortiz De Lejarazu, R" uniqKey="Ortiz De Lejarazu R" first="R" last="Ortiz De Lejarazu">R. Ortiz De Lejarazu</name>
<affiliation wicri:level="1"><nlm:affiliation>Raúl Ortiz de Lejarazu, Centro Nacional de Gripe de Valladolid. Hospital Clínico Universitario de Valladolid. Av. Ramón y Cajal, 3, 47003 Valladolid. Spain. rortizdelejarazu@saludcastillayleon.es.</nlm:affiliation>
<country wicri:rule="url">Espagne</country>
</affiliation>
</author>
<author><name sortKey="Diez Domingo, J" sort="Diez Domingo, J" uniqKey="Diez Domingo J" first="J" last="Díez Domingo">J. Díez Domingo</name>
</author>
<author><name sortKey="Gil De Miguel, A" sort="Gil De Miguel, A" uniqKey="Gil De Miguel A" first="A" last="Gil De Miguel">A. Gil De Miguel</name>
</author>
<author><name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N Torres">F. Martin N Torres</name>
</author>
<author><name sortKey="Guzman Quilo, C" sort="Guzman Quilo, C" uniqKey="Guzman Quilo C" first="C" last="Guzmán Quilo">C. Guzmán Quilo</name>
</author>
<author><name sortKey="Guillen, J M" sort="Guillen, J M" uniqKey="Guillen J" first="J M" last="Guillén">J M Guillén</name>
</author>
<author><name sortKey="Piedrafita, B" sort="Piedrafita, B" uniqKey="Piedrafita B" first="B" last="Piedrafita">B. Piedrafita</name>
</author>
<author><name sortKey="Redondo Marguello, E" sort="Redondo Marguello, E" uniqKey="Redondo Marguello E" first="E" last="Redondo Marguello">E. Redondo Marguello</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30421881</idno>
<idno type="pmid">30421881</idno>
<idno type="pmc">PMC6254476</idno>
<idno type="wicri:Area/Main/Corpus">00035</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00035</idno>
<idno type="wicri:Area/Main/Curation">000035</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000035</idno>
<idno type="wicri:Area/Main/Exploration">000035</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Description of Influenza B in seasonal epidemics in Spain].</title>
<author><name sortKey="Ortiz De Lejarazu, R" sort="Ortiz De Lejarazu, R" uniqKey="Ortiz De Lejarazu R" first="R" last="Ortiz De Lejarazu">R. Ortiz De Lejarazu</name>
<affiliation wicri:level="1"><nlm:affiliation>Raúl Ortiz de Lejarazu, Centro Nacional de Gripe de Valladolid. Hospital Clínico Universitario de Valladolid. Av. Ramón y Cajal, 3, 47003 Valladolid. Spain. rortizdelejarazu@saludcastillayleon.es.</nlm:affiliation>
<country wicri:rule="url">Espagne</country>
</affiliation>
</author>
<author><name sortKey="Diez Domingo, J" sort="Diez Domingo, J" uniqKey="Diez Domingo J" first="J" last="Díez Domingo">J. Díez Domingo</name>
</author>
<author><name sortKey="Gil De Miguel, A" sort="Gil De Miguel, A" uniqKey="Gil De Miguel A" first="A" last="Gil De Miguel">A. Gil De Miguel</name>
</author>
<author><name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N Torres">F. Martin N Torres</name>
</author>
<author><name sortKey="Guzman Quilo, C" sort="Guzman Quilo, C" uniqKey="Guzman Quilo C" first="C" last="Guzmán Quilo">C. Guzmán Quilo</name>
</author>
<author><name sortKey="Guillen, J M" sort="Guillen, J M" uniqKey="Guillen J" first="J M" last="Guillén">J M Guillén</name>
</author>
<author><name sortKey="Piedrafita, B" sort="Piedrafita, B" uniqKey="Piedrafita B" first="B" last="Piedrafita">B. Piedrafita</name>
</author>
<author><name sortKey="Redondo Marguello, E" sort="Redondo Marguello, E" uniqKey="Redondo Marguello E" first="E" last="Redondo Marguello">E. Redondo Marguello</name>
</author>
</analytic>
<series><title level="j">Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia</title>
<idno type="eISSN">1988-9518</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Epidemics (MeSH)</term>
<term>Geography (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (MeSH)</term>
<term>Influenza A virus (MeSH)</term>
<term>Influenza B virus (MeSH)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Seasons (MeSH)</term>
<term>Spain (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Espagne (épidémiologie)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Géographie (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (MeSH)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Virus de la grippe A (MeSH)</term>
<term>Virus influenza B (MeSH)</term>
<term>Épidémies (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Epidemics</term>
<term>Geography</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A virus</term>
<term>Influenza B virus</term>
<term>Seasons</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Géographie</term>
<term>Humains</term>
<term>Saisons</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Virus de la grippe A</term>
<term>Virus influenza B</term>
<term>Épidémies</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b>
</p>
<p>Seasonal influenza epidemics are a major public health concern. They are caused by the influenza A and B viruses; although the A virus is more prominent, influenza B virus infection causes a disease with similar characteristics. There are two phylogenetically distinct influenza B lineages (B/Victoria and B/Yamagata), only one of which is present in the trivalent vaccine formulated each season.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>Epidemiological data from the Spanish Influenza Surveillance System for 2007 to 2017 were reviewed to establish the relative proportion of each type of virus and the characterization of the B lineages in relation to the composition of the trivalent vaccine.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>The median proportion of B (2007-2017) was 27.2% (0.7%-74.8%) vs. 16.3% (0.4%-98.6%) for A-H3 and 44.2% (0.1%-98.0%) for pandemic A-H1N1 (20092017). The B lineages co-circulated in 8/10 seasons and there was mismatch with the B vaccine strain in 4/10 seasons. The B virus was dominant in 2007/08 and 2012/13 throughout Spain. There was a combination of dominance/codominance of influenza B and mismatch with the vaccine lineage in at least one third of epidemic seasons reviewed.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>Epidemiological information on influenza B has been less compiled in comparison with data on the A virus. Influenza virus type B is responsible for a significant number of cases in almost all seasons. The predominant B lineage in each season is unpredictable, affecting the protection conferred by the seasonal vaccine. Spanish epidemiological data support the rationale for a quadrivalent vaccine with both B virus lineages similarly to data from other settings.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30421881</PMID>
<DateCompleted><Year>2019</Year>
<Month>03</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>03</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1988-9518</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>31</Volume>
<Issue>6</Issue>
<PubDate><Year>2018</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia</Title>
<ISOAbbreviation>Rev Esp Quimioter</ISOAbbreviation>
</Journal>
<ArticleTitle>[Description of Influenza B in seasonal epidemics in Spain].</ArticleTitle>
<Pagination><MedlinePgn>511-519</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">ortiz5nov2018</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Seasonal influenza epidemics are a major public health concern. They are caused by the influenza A and B viruses; although the A virus is more prominent, influenza B virus infection causes a disease with similar characteristics. There are two phylogenetically distinct influenza B lineages (B/Victoria and B/Yamagata), only one of which is present in the trivalent vaccine formulated each season.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Epidemiological data from the Spanish Influenza Surveillance System for 2007 to 2017 were reviewed to establish the relative proportion of each type of virus and the characterization of the B lineages in relation to the composition of the trivalent vaccine.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The median proportion of B (2007-2017) was 27.2% (0.7%-74.8%) vs. 16.3% (0.4%-98.6%) for A-H3 and 44.2% (0.1%-98.0%) for pandemic A-H1N1 (20092017). The B lineages co-circulated in 8/10 seasons and there was mismatch with the B vaccine strain in 4/10 seasons. The B virus was dominant in 2007/08 and 2012/13 throughout Spain. There was a combination of dominance/codominance of influenza B and mismatch with the vaccine lineage in at least one third of epidemic seasons reviewed.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Epidemiological information on influenza B has been less compiled in comparison with data on the A virus. Influenza virus type B is responsible for a significant number of cases in almost all seasons. The predominant B lineage in each season is unpredictable, affecting the protection conferred by the seasonal vaccine. Spanish epidemiological data support the rationale for a quadrivalent vaccine with both B virus lineages similarly to data from other settings.</AbstractText>
<CopyrightInformation>©The Author 2018. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ortiz de Lejarazu</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Raúl Ortiz de Lejarazu, Centro Nacional de Gripe de Valladolid. Hospital Clínico Universitario de Valladolid. Av. Ramón y Cajal, 3, 47003 Valladolid. Spain. rortizdelejarazu@saludcastillayleon.es.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Díez Domingo</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gil de Miguel</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Martinón Torres</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Guzmán Quilo</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Guillén</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Piedrafita</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Redondo Marguello</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>spa</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Descripción de la gripe B en las epidemias estacionales de España.</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Spain</Country>
<MedlineTA>Rev Esp Quimioter</MedlineTA>
<NlmUniqueID>9108821</NlmUniqueID>
<ISSNLinking>0214-3429</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005843" MajorTopicYN="N">Geography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009981" MajorTopicYN="Y">Influenza B virus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30421881</ArticleId>
<ArticleId IdType="pii">ortiz5nov2018</ArticleId>
<ArticleId IdType="pmc">PMC6254476</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>BMC Infect Dis. 2015 Aug 21;15:357</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26289794</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Public Health. 2013 Mar;103(3):e43-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23327249</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Future Microbiol. 2015;10(9):1447-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26357957</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2016 Mar 3;12(3):699-708</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26360135</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Med. 2013 Jun 25;11:153</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23800265</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2016 Sep;12(9):2269-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27184622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2012 Jan;6(1):37-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21668663</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2016 Apr 2;12(4):993-1002</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26890005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Jun 06;9(6):e98437</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24905235</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Dec;78(23):12817-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15542634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2012 Dec 17;31(1):49-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23142300</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Braz J Infect Dis. 2016 Jan-Feb;20(1):81-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26626166</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2010 Sep 7;28 Suppl 4:D45-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20713260</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2017 Aug 25;66(2):1-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28841201</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Prev Med Hyg. 2016;57(1):E23-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27346936</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rev Esp Quimioter. 2015 Feb;28(1):39-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25690144</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2016 Sep;138(3):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27535144</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Mal Infect. 2017 Feb;47(1):11-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28062245</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1:3-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26256290</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2014 Dec 1;59(11):1519-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25139969</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2012 Jan;8(1):81-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22252006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2016 Sep;12(9):2259-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27166916</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
</list>
<tree><noCountry><name sortKey="Diez Domingo, J" sort="Diez Domingo, J" uniqKey="Diez Domingo J" first="J" last="Díez Domingo">J. Díez Domingo</name>
<name sortKey="Gil De Miguel, A" sort="Gil De Miguel, A" uniqKey="Gil De Miguel A" first="A" last="Gil De Miguel">A. Gil De Miguel</name>
<name sortKey="Guillen, J M" sort="Guillen, J M" uniqKey="Guillen J" first="J M" last="Guillén">J M Guillén</name>
<name sortKey="Guzman Quilo, C" sort="Guzman Quilo, C" uniqKey="Guzman Quilo C" first="C" last="Guzmán Quilo">C. Guzmán Quilo</name>
<name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N Torres">F. Martin N Torres</name>
<name sortKey="Piedrafita, B" sort="Piedrafita, B" uniqKey="Piedrafita B" first="B" last="Piedrafita">B. Piedrafita</name>
<name sortKey="Redondo Marguello, E" sort="Redondo Marguello, E" uniqKey="Redondo Marguello E" first="E" last="Redondo Marguello">E. Redondo Marguello</name>
</noCountry>
<country name="Espagne"><noRegion><name sortKey="Ortiz De Lejarazu, R" sort="Ortiz De Lejarazu, R" uniqKey="Ortiz De Lejarazu R" first="R" last="Ortiz De Lejarazu">R. Ortiz De Lejarazu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000046 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000046 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30421881
   |texte=   [Description of Influenza B in seasonal epidemics in Spain].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30421881" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021

	Serveur d'exploration sur la grippe en Espagne
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en Espagne

[Description of Influenza B in seasonal epidemics in Spain].

[Description of Influenza B in seasonal epidemics in Spain].

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki